Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...
There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...
Research has revealed clear evidence that changes in the orchestration of brain oxygenation dynamics and neuronal function in Alzheimer's disease contribute to the neurodegeneration. Researchers found ...
The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.
Xanamem has been granted a nonproprietary name by the World Health Organisation. Picture: AFP) Xanamem helps slow down the course of Alzheimer’s disease and address cognitive decline.